Literature DB >> 22285453

Japanese version of voice handicap index for subjective evaluation of voice disorder.

Aki Taguchi1, Kazuyo Mise, Kaori Nishikubo, Masamitsu Hyodo, Osamu Shiromoto.   

Abstract

Recently, the Voice Handicap Index (VHI), developed in the United States, has been highlighted as a means to assess a patient's perceptions of the severity of his or her voice disorder. The VHI is based on a self-administered questionnaire that quantifies the degree of a patient's disability related to his/her voice disorder. The questionnaire was translated into Japanese and applied to Japanese patients with various kinds of disordered voice or dysphonia. The results were analyzed and the usefulness discussed. In this study, 546 patients (281 males and 265 females) were included. Mean VHI scores were 36.2/120 in males and 44.1/120 in females. In the male patients, VHI scores were the highest among teens. However, VHI scores did not vary with age in the female patients. Patients with vocal fold paralysis, functional dysphonia, psychological dysphonia, and spasmodic dysphonia showed relatively high VHI scores, whereas those with laryngeal granuloma and laryngopharyngeal reflux disease showed low scores. In most diseases, functional and physiological scores were higher than emotional scores. In any treated patients, those with vocal nodule, vocal polyp, polypoid vocal fold, and recurrent laryngeal nerve paralysis, VHI scores decreased after therapeutic intervention. These findings suggest that the Japanese VHI is a useful tool for monitoring a patient's psychological status, choosing appropriate treatment, and assessing the therapeutic outcome.
Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22285453     DOI: 10.1016/j.jvoice.2011.11.005

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  9 in total

Review 1.  Voice outcomes following radiation versus laser microsurgery for T1 glottic carcinoma: systematic review and meta-analysis.

Authors:  Matthew T Greulich; Noah P Parker; Philip Lee; Albert L Merati; Stephanie Misono
Journal:  Otolaryngol Head Neck Surg       Date:  2015-04-02       Impact factor: 3.497

2.  The Norwegian Voice Handicap Index (VHI-N) patient scores are dependent on voice-related disease group.

Authors:  Tom Karlsen; John-Helge Heimdal; Anne Rita Hella Grieg; Hans Jørgen Aarstad
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-30       Impact factor: 2.503

3.  Articulation handicap index: an instrument for quantifying psychosocial consequences of impaired articulation.

Authors:  Annerose Keilmann; Uwe Konerding; Constantin Oberherr; Tadeus Nawka
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-17       Impact factor: 2.503

4.  Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.

Authors:  Masamitsu Hyodo; Asuka Nagao; Kento Asano; Masahiko Sakaguchi; Kenji Mizoguchi; Koichi Omori; Yasuhiro Tada; Hiromitsu Hatakeyama; Nobuhiko Oridate; Kensei Naito; Yoshihiro Iwata; Hirotaka Shinomiya; Hirotaka Hara; Tetsuji Sanuki; Eiji Yumoto
Journal:  Eur J Neurol       Date:  2021-01-23       Impact factor: 6.089

5.  Checking for voice disorders without clinical intervention: The Greek and global VHI thresholds for voice disordered patients.

Authors:  Dionysios Tafiadis; Spyridon K Chronopoulos; Meropi E Helidoni; Evangelia I Kosma; Louiza Voniati; Periklis Papadopoulos; Thomas Murry; Nafsika Ziavra; George A Velegrakis
Journal:  Sci Rep       Date:  2019-06-27       Impact factor: 4.379

6.  Seeking Medical Assistance for Dysphonia Is Associated with an Improved Survival Rate in Laryngeal Cancer: Real-World Evidence.

Authors:  Yi-An Lu; Ming-Shao Tsai; Li-Ang Lee; Shu-Ru Lee; Li-Yun Lin; Chain-Fen Chang; Wan-Ni Lin; Li-Jen Hsin; Chun-Ta Liao; Hsueh-Yu Li; Yu-Wen Wen; Tuan-Jen Fang
Journal:  Diagnostics (Basel)       Date:  2021-02-07

7.  Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.

Authors:  Kahori Hirose; Kento Asano; Masahiko Sakaguchi; Asuka Nagao; Maya Nakahira; Nao Doi; Taisuke Kobayashi; Masamitsu Hyodo
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-09-28

Review 8.  Functional dysphonia: strategies to improve patient outcomes.

Authors:  Mara Behlau; Glaucya Madazio; Gisele Oliveira
Journal:  Patient Relat Outcome Meas       Date:  2015-12-01

Review 9.  Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.

Authors:  Masamitsu Hyodo; Kento Asano; Asuka Nagao; Kahori Hirose; Maya Nakahira; Saori Yanagida; Noriko Nishizawa
Journal:  Toxins (Basel)       Date:  2021-11-25       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.